Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
503 studies found for:    glioma | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study
Condition: Glioma
Intervention: Procedure: Detecting of Biological Borders of Gliomas
2 Recruiting Fluorescence and Glioma Heterogeneity
Condition: Malignant Gliomas
Intervention: Procedure: ALA Test group
3 Recruiting Brain Glioma Registry Combining Clinical and Imaging Information
Condition: Adult Glioma
Intervention: Other: Brain Glioma Registry
4 Recruiting Case-cohort Study of Sedatives' Effects on Neurological Function in Patients With Eloquent Area Glioma
Condition: Glioma
Interventions: Drug: Midazolam;   Drug: propofol;   Drug: Dexmedetomidine
5 Recruiting A Vaccine Trial for Low Grade Gliomas
Condition: Low Grade Glioma
Intervention: Biological: Experimental: HLA-A2 Restricted Glioma Antigen-Peptides with Poly-ICLC
6 Recruiting 11C-Methionine PET as Prognostic Marker of Gliomas
Condition: Glioma
Intervention: Other: No intervention
7 Recruiting iMRI Guided Resection in Cerebral Glioma Surgery
Condition: Glioma
Interventions: Procedure: iMRI;   Procedure: conventional neuronavigation
8 Recruiting A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction With Poly-ICLC in Pediatric Gliomas
Conditions: Newly Diagnosed Pediatric Pontine Glioma;   Newly Diagnosed Pediatric High Grade Glioma;   Recurrent Pediatric High Grade Glioma;   Recurrent Pediatric Low Grade Glioma
Interventions: Biological: HLA-A2 restricted glioma antigen peptides vaccine;   Biological: Poly-ICLC
9 Not yet recruiting Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas
Condition: Recurrent High-grade Glioma
Interventions: Drug: Ultra-low dose Bevacizumab;   Drug: Temozolomide
10 Recruiting The Research on 89Zr-ABT806 PET Imaging in High Grade Glioma
Condition: Glioma
Intervention: Diagnostic Test: 89Zr-ABT806 PET
11 Recruiting Supratotal Resection for Gliomas Within Noneloquent Areas
Condition: Glioma
Interventions: Procedure: total resection;   Procedure: supratotal resection
12 Recruiting Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
Condition: OMS Grade II Glioma
Intervention: Behavioral: neurocognitive tests
13 Recruiting Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Conditions: Brain Cancer;   Glioma
Intervention: Procedure: MRI and advanced MRI sequences
14 Recruiting Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas
Condition: Glioma
Intervention: Drug: nilotinib
15 Recruiting Study of Orally Administered AG-881 in Patients With Advanced Solid Tumors, Including Gliomas, With an IDH1 and/or IDH2 Mutation
Condition: Glioma
Intervention: Drug: AG881
16 Recruiting Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
Conditions: Diffuse Intrinsic Pontine Glioma;   Brainstem Glioma
Intervention:
17 Recruiting Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas
Conditions: Low Grade Glioma;   Malignant Glioma
Intervention:
18 Recruiting 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma
Condition: Glioma
Intervention: Drug: 68Ga-BNOTA-PRGD2
19 Recruiting Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas
Condition: Glioma
Intervention: Biological: dendritic cells
20 Recruiting Non Invasive IDentification of Gliomas With IDH1 Mutation
Condition: Non Invasive Diagnosis of Glioma
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.